Hisamitsu Pharmaceutical Co (TSE:4530) EV-to-EBIT : 8.66 (As of May. 12, 2024)

Hisamitsu Pharmaceutical Co EV-to-EBIT Chart

Hisamitsu Pharmaceutical Co Annual Data
	Trend	Feb15	Feb16	Feb17	Feb18	Feb19	Feb20	Feb21	Feb22	Feb23	Feb24
EV-to-EBIT		Get a 7-Day Free Trial					9.79	33.57	11.84	10.20	8.98

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EV-to-EBIT	Get a 7-Day Free Trial															10.20	7.51	13.01	11.79	-

Competitive Comparison of Hisamitsu Pharmaceutical Co's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hisamitsu Pharmaceutical Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's EV-to-EBIT falls into.

Hisamitsu Pharmaceutical Co EV-to-EBIT Calculation

Hisamitsu Pharmaceutical Co's EV-to-EBIT for today is calculated as:

Hisamitsu Pharmaceutical Co's current Enterprise Value is 円166,345 Mil.
Hisamitsu Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円19,204 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co  (TSE:4530) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Hisamitsu Pharmaceutical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2023 is calculated as:

Hisamitsu Pharmaceutical Co's Enterprise Value for the quarter that ended in Nov. 2023 was 円232,915 Mil.
Hisamitsu Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円19,204 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description